Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer's Disease

Erstveröffentlichung
2020
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Oeckl, Patrick
Halbgebauer, Steffen
Anderl-Straub, Sarah
von Arnim, Christine A. F.
Diehl-Schmid, Janine
et al.
Institutions
UKU. Klinik für Neurologie
Published in
Journal of proteome research ; 19 (2020), 3. - S. 1310-1318. - ISSN 1535-3893. - eISSN 1535-3907
Link to publication
https://dx.doi.org/10.1021/acs.jproteome.9b00824
EU Project
NADINE / Nanosystems for the early Diagnosis of Neurodegenerative diseases / EC / FP7 / 246513
Keywords
Alzheimer's disease; beta-synuclein; Creutzfeldt-Jakob disease; mass spectrometry; synaptic blood biomarker; MRM; cerebrospinal fluid; dementia; CEREBROSPINAL-FLUID; ALPHA-SYNUCLEIN; DIAGNOSTIC-CRITERIA; PARKINSONS-DISEASE; DEGENERATION; NEUROGRANIN; GUIDELINES; PATHOLOGY; PLASMA
Dewey Decimal Group
DDC 570 / Life sciences
Metadata
Show full item record